Literature DB >> 31548806

Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.

M Sorin1, E L Franco2,3, A Quesnel-Vallée3,4.   

Abstract

Entities:  

Year:  2019        PMID： 31548806      PMCID： PMC6726272          DOI： 10.3747/co.26.4867

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  7 in total

1.  Access to cancer drugs in Canada: looking beyond coverage decisions.

Authors:  Roger Chafe; Anthony Culyer; Mark Dobrow; Peter C Coyte; Carol Sawka; Susan O'Reilly; Kara Laing; Maureen Trudeau; Sharon Smith; Jeffrey S Hoch; Steve Morgan; Stuart Peacock; Rick Abbott; Terrence Sullivan
Journal:  Healthc Policy       Date:  2011-02

2.  Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study.

Authors:  Nicola Allen; Stuart R Walker; Lawrence Liberti; Chander Sehgal; M Sam Salek
Journal:  CMAJ Open       Date:  2016-11-03

Review 3.  Universal prescription drug coverage in Canada: Long-promised yet undelivered.

Authors:  Steven G Morgan; Katherine Boothe
Journal:  Healthc Manage Forum       Date:  2016-10-15

4.  Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications.

Authors:  Sam M Salek; Sarah Lussier Hoskyn; Jeffrey Johns; Nicola Allen; Chander Sehgal
Journal:  Front Pharmacol       Date:  2019-02-18       Impact factor: 5.810

5.  Systemic cancer therapy: achievements and challenges that lie ahead.

Authors:  Michael O Palumbo; Petr Kavan; Wilson H Miller; Lawrence Panasci; Sarit Assouline; Nathalie Johnson; Victor Cohen; Francois Patenaude; Michael Pollak; R Thomas Jagoe; Gerald Batist
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

6.  Medication Burden of Treatment Using Oral Cancer Medications.

Authors:  Barbara A Given; Charles W Given; Alla Sikorskii; Eric Vachon; Asish Banik
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec

Review 7.  Canada's universal health-care system: achieving its potential.

Authors:  Danielle Martin; Ashley P Miller; Amélie Quesnel-Vallée; Nadine R Caron; Bilkis Vissandjée; Gregory P Marchildon
Journal:  Lancet       Date:  2018-02-23       Impact factor: 79.321
  7 in total
  2 in total

1.  Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.

Authors:  Christine Leong; Piotr Czaykowski; Marc Geirnaert; Alan Katz; Roxana Dragan; Marina Yogendran; Colette Raymond
Journal:  Can J Public Health       Date:  2021-01-20

Review 2.  Not All Canadian Cancer Patients Are Equal-Disparities in Public Cancer Drug Funding across Canada.

Authors:  Ceilidh MacPhail; Stephanie Snow
Journal:  Curr Oncol       Date:  2022-03-17       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.